Masson Lydie, Barbé Laure, Henaff Fanny, Ahmed Tasnuva, Le Moullac-Vaidye Béatrice, Peltier Cécile, Marchand Sarah S, Scherdel Pauline, Vibet Marie-Anne, Ruvoën-Clouet Nathalie, Elenga Narcisse, Imbert-Marcille Berthe-Marie, Gras-Le Guen Christèle, Le Pendu Jacques
Department of Pediatrics, University Hospital of Nantes, Nantes, France.
Nantes Université, Inserm, CNRS, Immunology and New Concepts in Immunotherapy, INCIT, Nantes, France.
Front Microbiol. 2023 Mar 10;14:1141652. doi: 10.3389/fmicb.2023.1141652. eCollection 2023.
Human rotaviruses attach to histo-blood group antigens glycans and null alleles of the , and genes seem to confer diminished risk of gastroenteritis. Yet, the true extent of this protection remains poorly quantified. Here, we conducted a prospective study to evaluate the risk of consulting at the hospital in non-vaccinated pediatric patients according to the ABO, FUT2 (secretor) and FUT3 (Lewis) polymorphisms, in Metropolitan France and French Guiana. At both locations, P genotypes were largely dominated by P [8]-3, with P [6] cases exclusively found in French Guiana. The FUT2 null (nonsecretor) and FUT3 null (Lewis negative) phenotypes conferred near full protection against severe gastroenteritis due to P [8]-3 strains (OR 0.03, 95% CI [0.00-0.21] and 0.1, 95% CI [0.01-0.43], respectively in Metropolitan France; OR 0.08, 95% CI [0.01-0.52] and 0.14, 95%CI [0.01-0.99], respectively in French Guiana). Blood group O also appeared protective in Metropolitan France (OR 0.38, 95% CI [0.23-0.62]), but not in French Guiana. The discrepancy between the two locations was explained by a recruitment at the hospital of less severe cases in French Guiana than in Metropolitan France. Considering the frequencies of the null ABO, Secretor and Lewis phenotypes, the data indicate that in a Western European population, 34% (95% CI [29%; 39%]) of infants are genetically protected against rotavirus gastroenteritis of sufficient severity to lead to hospital visit.
人轮状病毒附着于组织血型抗原聚糖,而 、 和 基因的无效等位基因似乎可降低患肠胃炎的风险。然而,这种保护作用的真实程度仍未得到充分量化。在此,我们进行了一项前瞻性研究,以评估法国本土和法属圭亚那未接种疫苗的儿科患者根据ABO、FUT2(分泌型)和FUT3(Lewis)多态性在医院就诊的风险。在这两个地点,P基因型主要以P[8]-3为主,P[6]病例仅在法属圭亚那发现。FUT2无效(非分泌型)和FUT3无效(Lewis阴性)表型对P[8]-3毒株引起的严重肠胃炎几乎提供了完全保护(在法国本土,OR分别为0.03,95%CI[0.00 - 0.21]和0.1,95%CI[0.01 - 0.43];在法属圭亚那,OR分别为0.08,95%CI[0.01 - 0.52]和0.14,95%CI[0.01 - 0.99])。血型O在法国本土也显示出保护作用(OR 0.38,95%CI[0.23 - 0.62]),但在法属圭亚那则不然。两个地点之间的差异是由于法属圭亚那医院招募的病例比法国本土的病情较轻。考虑到无效ABO、分泌型和Lewis表型的频率,数据表明在西欧人群中,34%(95%CI[29%;39%])的婴儿在基因上受到保护,可抵御足以导致住院的轮状病毒肠胃炎。